Genpharmasec Ltd — Important, 09-02-2026: Company Update

Genpharmasec has confirmed no deviation in the use of proceeds from its Rights Issue, which raised Rs 48.45 crore. The company utilized these funds as originally planned, including for acquiring equity shares, repaying borrowings, funding working capital, and general corporate purposes. This latest update assures investors that the capital raised is being deployed according to its stated objectives, aligning with shareholder expectations and reflecting transparent financial management.